FIM
CLB icon

Fernwood Investment Management’s Core Laboratories CLB Stock Holding History

Fernwood Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-544
Closed -$9.29K – 280
2024
Q1 		$9.29K Buy
+544
New +$8.55K ﹤0.01% 579
2019
Q2 		– Sell
-3,620
Closed -$250K – 155
2019
Q1 		$250K Sell
3,620
-80
-2% -$5.36K 0.13% 132
2018
Q4 		$221K Sell
3,700
-3,200
-46% -$276K 0.14% 127
2018
Q3 		$799K Buy
6,900
+400
+6% +$45.1K 0.42% 64
2018
Q2 		$820K Hold
6,500
– – 0.44% 65
2018
Q1 		$703K Buy
6,500
+600
+10% +$66.4K 0.39% 69
2017
Q4 		$646K Buy
5,900
+300
+5% +$29.9K 0.35% 70
2017
Q3 		$553K Buy
5,600
+1,295
+30% +$126K 0.35% 70
2017
Q2 		$436K Buy
4,305
+800
+23% +$86.3K 0.32% 89
2017
Q1 		$405K Buy
+3,505
New +$407K 0.32% 84

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Fernwood Investment Management's CLB Position: Q2 2024 in Review

Fernwood Investment Management sold out of Core Laboratories (CLB) in Q2 2024, closing a stake of 544 shares — an estimated $9.29K sold.

Fernwood Investment Management first reported a position in CLB in Q1 2017 and held it in 10 quarters. The position peaked at $820K in Q2 2018. 194 funds tracked by Wall St. Rank hold CLB as of Q2 2024.

  • Fernwood Investment Management reported no remaining Core Laboratories position as of Q2 2024 after selling out during the quarter.
  • Fernwood Investment Management sold 544 Core Laboratories shares in Q2 2024, an estimated $9.29K.
  • Fernwood Investment Management first reported a position in Core Laboratories in Q1 2017 and held it in 10 quarters.
  • Fernwood Investment Management's Core Laboratories position peaked at $820K in Q2 2018.
  • 194 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2024.

Based on Fernwood Investment Management's 13F filing for Q2 2024, filed 31 Jul 2024.